Search Results for "Ranbaxy Launches Atorvastatin In Us"
Matching Channels
Statins (HMG-CoA reductase inhibitors) - a class of drug used to lower cholesterol levels
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol...
Lipitor was the best selling drug in 2009, with the 2009 annual sales coming in at over $5m for its company, Pfizer Inc. Lipitor is the brand name for an atorvastatin calcium medication that is pres...
Matching News
Ranbaxy restarts generic atorvastatin production
India-based generics giant Ranbaxy Laboratories (Ranbaxy) announced on 25 February 2013 that it has restarted production of its generic cholesterol lowering drug atorvastatin after solving contaminati...
Ranbaxy holds US atorvastatin share with generic Actos, Diovan launches on track
Foreign exchanges losses dented the boost the US launch of atorvastatin has proved Ranbaxy Laboratories. Second quarter forex losses, net, on foreign currency option derivatives taken during previous...
FDA Statement on the Ranbaxy Atorvastatin Recall
[11/29/2012] On Nov. 9, 2012, Ranbaxy Pharmaceuticals informed its customers of a voluntary recall of certain lots of the company’s 10mg, 20mg, and 40mg dosage strengths of atorvastatin tablets....
Spotlight on Indian site in Ranbaxy atorvastatin US recall
Some details on the potential cause of Ranbaxy’s voluntary recall of 41 lots of atorvastatin calcium tablets, generic versions of Pfizer's cholesterol lowering drug, Lipitor, in the US over conc...
'Troublesome' or not? Ranbaxy recalls US atorvastatin lots but hints at quick resolution
Shares of Ranbaxy fell by more than 3% on Indian bourses after the company said that it was recalling certain lots of atorvastatin calcium tablets, generic versions of Pfizer's cholesterol lowering d...
Ranbaxy recalls generic atorvastatin in US
Ranbaxy Pharmaceuticals (Ranbaxy) has fallen foul of FDA once again. The Indian generics major announced on its US website that it is conducting a voluntary recall for certain batches of its atorvasta...
Forex, derivatives seen hurting Ranbaxy in Q4 amid atorvastatin woes
Foreign exchange and derivatives issues are expected to dent Ranbaxy’s performance for the fourth quarter ended December 2012, amid concerns pertaining to the recall of certain lots of its gener...
Ranbaxy Halts Atorvastatin Production; Too Late for Mylan to Say “I Told You So?”
One year after the biggest generic drug launch in history, Ranbaxy is halting production of atorvastatin after a manufacturing quality glitch. FDA should be grateful this didn’t happen in the first...
Matching PubMed Articles
UGT1A1*28 is Associated with Decreased Systemic Exposure of Atorvastatin Lactone.
BACKGROUND: Atorvastatin is commonly used to reduce cholesterol. Atorvastatin acid is converted to its corresponding lactone form spontaneously or via glucuronidation mediated by uridine diphosphate g...
No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin.
Objectives: Dalcetrapib, which targets cholesteryl ester transfer protein, is in clinical development for prevention of cardiovascular events and is likely to be used concomitantly with statins. Two s...
Co-chemoprevention of mouse lung tumors by SAHA and atorvastatin.
Atorvastatin and SAHA were evaluated for co-chemoprevention of mouse lung tumors. In Experiment 1, lung tumors were induced by vinyl carbamate in strain A/J mice followed by 500 mg/kg SAHA, 60 or 180...
Abstract Objective: This study used simulation to compare the effectiveness of rosuvastatin 20 mg vs. atorvastatin 40 mg, and rosuvastatin 40 mg vs. atorvastatin 80 mg in preventing MACE in a range of...
Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia.
Background Serum proprotein convertase subtilisin/kexin 9 (PCSK9) binds to low-density lipoprotein (LDL) receptors, increasing the degradation of LDL receptors and reducing the rate at which LDL chole...
